Avior Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Avior Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26M	Buy	37,305 +11,151	+43%	+$334K	0.03%	322
2026 Q1	$760K	Hold	26,154	–	–	0.02%	422
2025 Q4	$685K	Sell	26,154 -2,321	-8%	-$59.7K	0.02%	383
2025 Q3	$672K	Buy	28,475 +476	+2%	+$10.5K	0.02%	384
2025 Q2	$574K	Buy	27,999 +232	+0.8%	+$4.67K	0.02%	400
2025 Q1	$569K	Buy	27,767 +1,117	+4%	+$24.9K	0.02%	372
2024 Q4	$603K	Buy	26,650 +17,150	+181%	+$412K	0.02%	398
2024 Q3	$234K	Buy	+9,500	New	+$232K	0.01%	661
2023 Q3	–	Sell	-91	Closed	-$2.13K	–	1637
2023 Q2	$2.13K	Hold	91	–	–	﹤0.01%	1347
2023 Q1	$2.12K	Buy	+91	New	+$2.28K	﹤0.01%	1386

Other funds holding IDNA

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.36B AUM 18.79% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PCA

Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 23.67% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

Avior Wealth Management's IDNA Position: Q2 2026 in Review

Avior Wealth Management increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 43% in Q2 2026, buying an estimated $334K and bringing the position to 37,305 shares worth $1.26M. The position accounts for 0.03% of the portfolio, ranked #322.

Avior Wealth Management first reported a position in IDNA in Q1 2023 and has held it in 10 quarters since. 33 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Avior Wealth Management held 37,305 shares of iShares Genomics Immunology and Healthcare ETF worth $1.26M as of Q2 2026.
Avior Wealth Management bought 11,151 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $334K.
iShares Genomics Immunology and Healthcare ETF made up 0.03% of Avior Wealth Management's portfolio in Q2 2026, its #322 holding.
Avior Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2023 and has held it in 10 quarters since.
33 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.